Fig. 5
From: Immunological classification of gliomas based on immunogenomic profiling
Comparisons of pathway activity, gene ontology, and tumor phenotypes between the glioma immune subtypes. a Immune- and cancer-associated pathways highly enriched in immunity-high versus immunity-low identified by GSEA [21]. b The positive correlation between cancer-associated pathways enriched in immunity-high and immune scores versus the negative correlation between the pathways enriched in immunity-low and immune scores. Spearman’s correlation test p values and correlation coefficients (ρ) are indicated. c Nine gene modules (gene ontology) that significantly differentiated gliomas by subtype, survival time, or survival status identified by WGCNA [22]. d Immunity-high has significantly higher tumor stemness and epithelial-mesenchymal transition (EMT) scores than immunity-low gliomas